Why Viking Therapeutics Stock Zoomed 5% Higher Today
Good news from a peer and a positive analyst update were the elements driving Viking Therapeutics (NASDAQ: VKTX) stock higher on the first trading day of the week.
The clinical-stage biotech, closely watched by some because of its investigational weight-loss drug VK2735, saw its share price improve by more than 5% as a result. By contrast, the S 500 index basically traded flat across the trading session.
The news driving Viking and other obesity drug developers came from a leading company in that space, Wegovy maker Novo Nordisk.
Source Fool.com
Viking Therapeutics Inc Stock
€25.39
0.100%
Our community is currently high on Viking Therapeutics Inc with 4 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 25 € is below the current price of 25.39 € for Viking Therapeutics Inc, so the potential is actually -1.54%.
